Atlas Venture Advisors, Inc. - MIRAGEN THERAPEUTICS INC ownership

MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 57 filers reported holding MIRAGEN THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Atlas Venture Advisors, Inc. ownership history of MIRAGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$2,451,000
-29.7%
3,142,5800.0%0.41%
-53.7%
Q2 2020$3,488,000
+146.7%
3,142,5800.0%0.89%
-53.5%
Q1 2020$1,414,000
-6.2%
3,142,5800.0%1.91%
-16.0%
Q4 2019$1,508,000
-34.3%
3,142,5800.0%2.28%
+219.5%
Q3 2019$2,297,000
-64.3%
3,142,5800.0%0.71%
-73.3%
Q2 2019$6,442,000
-26.5%
3,142,5800.0%2.67%
-39.8%
Q1 2019$8,768,000
-7.9%
3,142,5800.0%4.43%
-11.9%
Q4 2018$9,522,0003,142,5805.03%
Other shareholders
MIRAGEN THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 105,465$965,0002.31%
BIEGEL & WALLER LLC 66,508$609,0000.38%
BSW Wealth Partners 22,236$203,0000.09%
Artal Group S.A. 100,000$915,0000.02%
PRIO WEALTH LIMITED PARTNERSHIP 12,895$117,0000.01%
Virtu Financial LLC 10,976$100,0000.01%
PRELUDE CAPITAL MANAGEMENT, LLC 6,500$59,0000.01%
FMR LLC 3,124,888$28,593,0000.00%
SG Americas Securities, LLC 27,283$250,0000.00%
HighTower Advisors, LLC 21,034$194,0000.00%
View complete list of MIRAGEN THERAPEUTICS INC shareholders